Temozolomide Capsule
Product Images NDC 16729-049

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 16729-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Temo 100mg 5cap Amber Cart)

This is a description of a medication named Temozolomide in capsule form. The capsules are 100mg emezolmi USP and are packaged in varying strengths for different dosages. The medication is cytotoxic and should not be opened. The recommended daily dose should be established through the accompanying directions. The capsules should be stored between 15° to 30°C (50° to 86°F). The medication is manufactured by N Accord Milpharm Limited.*

FDA Label Image

Temo 100mg 5cap Sachet Cart

This is a medication package for Temozolomide Capsules USP, used for cancer treatment. Each capsule contains 100mg of Temozolomide. The package contains five individual sachets, with one capsule in each. The package also includes directions for use and information about storage. It is for prescription use only. The manufacturer is Accord Healthcares, Inc in Durham, NC. The package includes dispensing information and was produced by Intas Pharmaceuticals Limited, located in Ahmedabad, India.*

FDA Label Image

Principal Display Panel (Temo 140mg 5cap Amber Cart)

This is a description of Temozolomide Capsules USP. The capsules come in a package of 5, with each capsule containing 140mg of temozolomide USP. It is specified that the capsules should not be opened but swallowed whole, and avoid contact with skin, eyes, or nose. The recommended dose is to be checked in the package insert for different capsule strengths. The manufacturer is Accord Healthcare, Durham, NC and it was manufactured in India. Storage temperature is advised to be at 25°C (17°F), and they should be dispensed in tight, light-resistant containers or kept in the original bottle.*

FDA Label Image

Temo 140mg 5cap Sachet Cart

This is a product description for Temozolomide Capsules USP. The capsules come in varying strengths and should be swallowed whole without being opened. If the capsule is damaged, contact with skin, eyes or nose should be avoided. The package contains 5 individual sachets, each containing one capsule. The storage temperature is recommended at 25°C (77°F). Directions must be carefully read before use. There is a warning to pregnant women regarding special dispensing information. The manufacturer is Accord Healthcare, Inc. The product details are consistent with medical information for Temozolomide Capsules USP.*

FDA Label Image

Principal Display Panel (Temo 180mg 5cap Amber Cart)

This is a description of Temozolomide Capsules USP with a manufacturing company located in India. Each capsule contains 180mg and the recommended dose varies based on the package insert. The capsules should be stored at 25°C and dispensed in containers as defined in USPINF or retained in the original bottle. The text includes some specific instructions and regulatory information, but does not contain a general information on the medication.*

FDA Label Image

Temo 180mg 5cap Sachet Cart

This is a medication called Temozolomide, which comes in capsules with a strength of 180 mg. The recommended dosage depends on the individual patient, and it should be stored at a temperature of 25°C (77°F). The package contains 5 sachets of individual capsules, and it is only available through prescription. It includes cautionary information for pregnant women and a warning to avoid contact with damaged capsules. The medication is manufactured by Accord Healthcare, Inc. in Durham, NC, and distributed by Intas Pharmaceuticals Limited in India.*

FDA Label Image

Principal Display Panel (Temo 20mg 5cap Amber Cart)

This is a description of Temozolomide capsules USP, manufactured by Accord Healthcare, Inc. The capsules are available in different strengths (20 mg each), and the recommended dosage is 12 capsules to be taken whole. The accompanying instructions should be read carefully before use. The capsules should not be opened and must be stored at room temperature, with permitted excursions between 15°C and 30°C. The capsules should be kept in their original container, which is designed to be airtight and resistant to high temperatures.*

FDA Label Image

Temo 20mg 5cap Sachet Cart

This is a description of medication Temozolomide in capsule form. The package is labeled with the drug name, Rx Only, and the manufacturer's details. The package contains 5 sachets, each containing one capsule of 20 mg. It is noteworthy that the capsules should not be opened or damaged; otherwise, contact with skin or nose should be avoided. The package suggests referring to the enclosed instructions for the recommended dose. The capsules should be kept at 25°C, with permissible excursions from 15°C to 30°C. Furthermore, there is a special dispensing information included that pharmacists are required to review carefully.*

FDA Label Image

Principal Display Panel (Temo 250mg 5cap Amber Cart)

This is a medication called Temozolomide which comes in capsule form and is available only by prescription. The strength of each capsule is 250mg, and the medication is manufactured for Accord Healthcare, Inc in Durham, NC, USA. The manufacturer is Intas Pharmaceuticals Limited in Ahmedabad, India. The package includes five capsules and should be stored at 25°C (77°F) or USP Controlled Room Temperature. It is recommended to read the accompanying directions before using the medication. The capsules should not be opened, but swallowed whole.*

FDA Label Image

Temo 250mg 5cap Sachet Cart

This is a package of Temozolomide 250mg capsules USP, manufactured for Accord Healthcare Inc. The package contains 5 individual sachets with one capsule in each. The capsules should not be opened and should be swallowed whole. It is recommended to follow the directions carefully while using the product. The usual dose can be found in the package directions. The capsules should be stored at a temperature between 15°C to 30°C (59°F to 86°F). There is special dispensing information included, therefore pharmacist attention is required while dispensing the product.*

FDA Label Image

Principal Display Panel (Temo 5mg 5cap Amber Cart)

This is a description of Temozolomide capsules which are used for medical purposes. The text contains information about dosage, packaging, storage, and dispensing of the medicine. There is a caution to read accompanying instructions carefully. The manufacturer of these capsules is located in India.*

FDA Label Image

Temo 5mg 5cap Sachet Cart

This is a drug information sheet for Temozolomide Capsules USP, which consists of five individual sachets with a capsule inside each sachet. The package contains special dispensing information for pharmacists, and each capsule contains 5 mg of temozolomide. The instructions caution against opening the capsule and recommend swallowing the whole capsule. The usual dosage and storage instructions are included. It was manufactured by Intas Pharmaceuticals Limited in India and is distributed by Accord Healthcare, Inc. in Durham, NC.*

FDA Label Image

Figure 1: Kaplan-meier Curves For Overall Survival (itt Population) (Temo Figure 1)

This appears to be a statistical analysis report of a medical or clinical trial study on overall survival of a certain population. The study includes information on probability and a hazard ratio (HR) with a confidence interval of 85%. The log-rank p-value is less than 0.0001, indicating a significant difference in survival between groups. There is also a graph or chart showing the percentage survival over a period of 24 months from randomization.*

FDA Label Image

Chemical Structure (Temo Structure)

FDA Label Image

Table 1 (Temo Table 1)

This is a dosing modification table for refractory anaplastic astrocytoma. It specifies the starting dose and measurement days for ANC and platelets to determine if the dosage needs adjustment. If ANC and platelets are too low, therapy must be postponed until the counts reach the required levels. If counts are within ranges specified, therapy can continue with the initial dose or increased dose applied for subsequent cycles.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.